Defects in immune response to Toxoplasma gondii are associated with enhanced HIV-1-related neurocognitive impairment in co-infected patients
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285976 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Edwin Eliel Escobar-Guevara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular Immunophysiology, José Maria Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela. Hauptthemen laut MEDLINE: Toxoplasma, HIV-1, Coinfection, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Ciencia Tecnología e Innovación, Instituto Venezolano de Investigaciones Científicas.
Abstract (Originalsprache)
Human immunodeficiency virus-1 (HIV-1) and Toxoplasma gondii can invade the central nervous system and affect its functionality. Advanced HIV-1 infection has been associated with defects in immune response to T . gondii , leading to reactivation of latent infections and development of toxoplasmic encephalitis. This study evaluates relationship between changes in immune response to T . gondii and neurocognitive impairment in HIV-1/ T . gondii co-infected patients, across different stages of HIV-1 infection. The study assessed the immune response to T . gondii by measuring cytokine production in response to parasite antigens, and also neurocognitive functions by performing auditory and visual P300 cognitive evoked potentials, short term memory (Sternberg) and executive function tasks (Wisconsin Card Sorting Test-WCST) in 4 groups of individuals: HIV-1/ T . gondii co-infected (P2), HIV-1-infected/ T . gondii- non-infected (P1), HIV-1-non-infected/ T . gondii- infected (C2) and HIV-1-non-infected/ T . gondii- non-infected (C1). Patients (P1 and P2) were grouped in early/asymptomatic (P1A and P2A) or late/symptomatic (P1B/C and P2B/C) according to peripheral blood CD4+ T lymphocyte counts (>350 or
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Cellular Immunophysiology, José Maria Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela.
- Department of Immunology, José Maria Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela.
- Laboratory of Physiopathology, Venezuelan Institute for Scientific Research, Caracas, Venezuela.
- Department of Physiopathology, José Maria Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela.
- Service of Infectology, José Ignacio Baldó Hospital, Caracas, Venezuela.
- Department of Microbiology, José Maria Vargas School of Medicine, Central University of Venezuela, Caracas, Venezuela.
ORCID-Profile: Edwin Eliel Escobar-Guevara
Förderung
- Fondo Nacional de Ciencia Tecnología e Innovación
- Instituto Venezolano de Investigaciones Científicas
Zitieren
APA
Escobar-Guevara, E. E., de Quesada-Martínez, M. E., Roldán-Dávila, Y. B., Alarcón de Noya, B., & Alfonzo-Díaz, M. A. (2023). Defects in immune response to Toxoplasma gondii are associated with enhanced HIV-1-related neurocognitive impairment in co-infected patients. PLOS ONE. https://doi.org/10.1371/journal.pone.0285976
Vancouver
Escobar-Guevara EE, de Quesada-Martínez ME, Roldán-Dávila YB, Alarcón de Noya B, Alfonzo-Díaz MA. Defects in immune response to Toxoplasma gondii are associated with enhanced HIV-1-related neurocognitive impairment in co-infected patients. PLOS ONE. 2023. doi:10.1371/journal.pone.0285976
BibTeX
@article{EscobarGuevara2023,
author = {Escobar-Guevara, Edwin Eliel and de Quesada-Martínez, María Esther and Roldán-Dávila, Yhajaira Beatriz and Alarcón de Noya, Belkisyolé and Alfonzo-Díaz, Miguel Antonio},
title = {Defects in immune response to Toxoplasma gondii are associated with enhanced HIV-1-related neurocognitive impairment in co-infected patients},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285976}
}
EUVIMED